Tag: merck

March 9, 2020

8 Small Biotech ETFs

Want to invest in small biotech ETFs? Here we profile eight that life science investors may want to look into.
February 27, 2020

Barclays Sees Upside in US Biopharma Industry

Barclays Capital has initiated coverage of the US biopharma space and will follow 16 companies in the market.
February 5, 2020

Merck Announces Q4 and Full-Year 2019 Financial Results

Merck reported quarterly sales at US$11.9 billion in Q4 in its financial results for the fourth quarter of 2019 and...
November 12, 2019

NewLink Genetics Receives European Commission Grant of Conditional Marketing Approval for V920

The European Commission has granted a conditional marketing authorization to ERVEBO, an investigational V920 Ebola Zaire vaccine.
October 15, 2019

Blockchain Update: Q3 2019 in Review

In this blockchain update, INN highlights the major trends that took place over the third quarter, from hedging to institutionalization.
September 18, 2019

NewLink Genetics Receives FDA Acceptance for Partnered Biologics License Application

NewLink Genetics (NASDAQ:NLNK) has announced that the US Food and Drug Administration has accepted Merck’s (NYSE:MRK)’s Biologics License Application and...
August 28, 2019

10 Top Pharma Companies by Revenue

We break down the top pharma companies by revenue in 2018, according to information from research firm GlobalData.